EP3910071A4 - Nanovesikel aus bakterien der gattung lactococcus und deren verwendung - Google Patents

Nanovesikel aus bakterien der gattung lactococcus und deren verwendung Download PDF

Info

Publication number
EP3910071A4
EP3910071A4 EP20738319.1A EP20738319A EP3910071A4 EP 3910071 A4 EP3910071 A4 EP 3910071A4 EP 20738319 A EP20738319 A EP 20738319A EP 3910071 A4 EP3910071 A4 EP 3910071A4
Authority
EP
European Patent Office
Prior art keywords
nanovesicles
bacteria
genus rhodococcus
rhodococcus
genus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20738319.1A
Other languages
English (en)
French (fr)
Other versions
EP3910071A1 (de
Inventor
Yoon-Keun Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MD Healthcare Inc
Original Assignee
MD Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MD Healthcare Inc filed Critical MD Healthcare Inc
Priority claimed from PCT/KR2020/000342 external-priority patent/WO2020145663A1/ko
Publication of EP3910071A1 publication Critical patent/EP3910071A1/de
Publication of EP3910071A4 publication Critical patent/EP3910071A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
EP20738319.1A 2019-01-09 2020-01-08 Nanovesikel aus bakterien der gattung lactococcus und deren verwendung Withdrawn EP3910071A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190002609 2019-01-09
KR1020200002274A KR102284589B1 (ko) 2019-01-09 2020-01-07 로도코커스 속 세균 유래 나노소포 및 이의 용도
PCT/KR2020/000342 WO2020145663A1 (ko) 2019-01-09 2020-01-08 로도코커스 속 세균 유래 나노소포 및 이의 용도

Publications (2)

Publication Number Publication Date
EP3910071A1 EP3910071A1 (de) 2021-11-17
EP3910071A4 true EP3910071A4 (de) 2022-10-12

Family

ID=71832408

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20738319.1A Withdrawn EP3910071A4 (de) 2019-01-09 2020-01-08 Nanovesikel aus bakterien der gattung lactococcus und deren verwendung

Country Status (3)

Country Link
EP (1) EP3910071A4 (de)
KR (1) KR102284589B1 (de)
CN (1) CN113286897A (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
WO2018155961A1 (ko) * 2017-02-24 2018-08-30 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 파킨슨병 진단방법
KR20180098163A (ko) * 2017-02-24 2018-09-03 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 만성폐쇄성기도질환 진단 방법
EP3696284A1 (de) * 2017-10-13 2020-08-19 MD Healthcare Inc. Verfahren zur diagnose von alzheimer-demenz durch bakterielle metagenome analyse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101923969B1 (ko) 2016-07-08 2018-11-30 주식회사 엠디헬스케어 프로피오니박테리움 속 세균 유래 나노소포 및 이의 용도
WO2018124619A1 (ko) * 2016-12-26 2018-07-05 주식회사 엠디헬스케어 미생물 메타게놈 분석을 통한 방광암 진단방법
WO2018155950A1 (ko) * 2017-02-24 2018-08-30 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 당뇨병 진단 방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
WO2018155961A1 (ko) * 2017-02-24 2018-08-30 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 파킨슨병 진단방법
KR20180098163A (ko) * 2017-02-24 2018-09-03 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 만성폐쇄성기도질환 진단 방법
EP3696284A1 (de) * 2017-10-13 2020-08-19 MD Healthcare Inc. Verfahren zur diagnose von alzheimer-demenz durch bakterielle metagenome analyse

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020145663A1 *

Also Published As

Publication number Publication date
CN113286897A (zh) 2021-08-20
KR20200086639A (ko) 2020-07-17
KR102284589B1 (ko) 2021-08-03
EP3910071A1 (de) 2021-11-17

Similar Documents

Publication Publication Date Title
EP3816282A4 (de) Luciferin-biosyntheseenzyme und ihre verwendung
EP3786299A4 (de) Transformante von bakterien der gattung hydrogenophilus
EP3303634A4 (de) Cas9-varianten und verfahren zur verwendung davon
IL282441A (en) Conjugated chemical inducers of degradation and methods of use
EP3399984A4 (de) Modulatoren von 5'-nukleotidase, ecto und verwendung davon
EP3819572A4 (de) Schubladenanordnung und mit der schubladenanordnung ausgestatteter kühlschrank
EP3706743A4 (de) Modifizierte ligandengesteuerte ionenkanäle und verfahren zur verwendung
IL284561A (en) Prostate neoantigens and their uses
WO2016057942A3 (en) Portable induction electrospraying apparatus and kit
EP3946315A4 (de) Cannabinoide zusammensetzungen und verwendung davon
EP3722715A4 (de) Aufbau einer schubladenanordnung und kühlschrank damit
MA49019A (fr) Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
EP3758714A4 (de) Verfahren und zusammensetzungen zur behandlung des angelman-syndroms
EP3589290A4 (de) Translatierbare moleküle und deren synthese
EP3962956A4 (de) Anti-hvem-antikörper und verwendung davon
IL280728A (en) Microorganism mixtures, molecules derived therefrom, and methods of use thereof
MA50440A (fr) Imidazopyridinamides substituées et leur utilisation
EP3331526A4 (de) Nikotinabbauende enzyme zur behandlung von nikotinabhängigkeit und nikotinvergiftung
EP3514192A4 (de) Hohlpartikel und verwendung davon
EP3319682A4 (de) Ventilanordnung und verfahren zur verwendung
IL290217B2 (en) Communication system and its use
MA47450A (fr) Sulfinylpyridines et leur utilisation dans le traitement du cancer
PL3814139T3 (pl) Urządzenie i sposób oddzielania tafli szkła bezpiecznego zespolonego
EP3313407A4 (de) Behandlung und verwaltung der augmentation beim syndrom der unruhigen beine
EP3383886A4 (de) Histatine und verfahren zur verwendung davon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210716

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220908

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/74 20150101ALI20220902BHEP

Ipc: A61K 9/00 20060101ALI20220902BHEP

Ipc: A23L 33/135 20160101ALI20220902BHEP

Ipc: C12Q 1/6886 20180101ALI20220902BHEP

Ipc: C12Q 1/689 20180101ALI20220902BHEP

Ipc: C12Q 1/6883 20180101AFI20220902BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231219

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250614